|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07H 21/04 | |
| C12N 15/09 |
| (11) | Number of the document | 2625189 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11830067.2 |
| Date of filing the European patent application | 2011-10-03 | |
| (97) | Date of publication of the European application | 2013-08-14 |
| (45) | Date of publication and mention of the grant of the patent | 2018-06-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/054636 |
| Date | 2011-10-03 |
| (87) | Number | WO 2012/045082 |
| Date | 2012-04-05 |
| (30) | Number | Date | Country code |
| 404413 P | 2010-10-01 | US |
| (72) |
SCHRUM, Jason, US
SIECZKIEWICZ, Gregory, J., US
EJEBE, Kenechi, US
ELBASHIR, Sayda, US
|
| (73) |
ModernaTX, Inc.,
320 Bent Street, Cambridge, MA 02141,
US
|
| (54) | ENGINEERED NUCLEIC ACIDS AND METHODS OF USE THEREOF |
| ENGINEERED NUCLEIC ACIDS AND METHODS OF USE THEREOF |